The risk of adverse clinical outcomes following treatment of Plasmodium vivax malaria with and without primaquine in Papua, Indonesia.
The widespread use of primaquine (PQ) radical cure for P. vivax, is constrained by concerns over its safety. We used routinely collected patient data to compare the overall morbidity and mortality in patients treated with and without PQ without prior testing of Glucose-6-Phosphate-Dehydrogenase (G6P...
Main Authors: | Kamala Thriemer, Jeanne-Rini Poespoprodjo, Enny Kenangalem, Nicholas M Douglas, Paulus Sugiarto, Nicholas M Anstey, Julie Anne Simpson, Ric N Price |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2020-11-01
|
Series: | PLoS Neglected Tropical Diseases |
Online Access: | https://doi.org/10.1371/journal.pntd.0008838 |
Similar Items
-
Safety of primaquine in infants with Plasmodium vivax malaria in Papua, Indonesia
by: Agus Setyadi, et al.
Published: (2019-04-01) -
The risk of adverse clinical outcomes following treatment of Plasmodium vivax malaria with and without primaquine in Papua, Indonesia
by: Thriemer, K, et al.
Published: (2020) -
Safety of primaquine in infants with Plasmodium vivax malaria in Papua, Indonesia
by: Setyadi, A, et al.
Published: (2019) -
Unsupervised primaquine for the treatment of Plasmodium vivax malaria relapses in southern Papua: A hospital-based cohort study
by: Douglas, NM, et al.
Published: (2017) -
Malaria-related hospitalization during childhood in Papua, Indonesia: A retrospective cohort study.
by: Nicholas M Douglas, et al.
Published: (2020-01-01)